TuHURA Biosciences, Inc. HURA Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Richtech Robotics Inc.RR

$118K+15.7%

CelcuityCELC

$195.57M—

WolfspeedWOLF

$798.3M-73.8%

SKYX Platforms Corp.SKYX

$14.52M+78.1%

Cineverse Corp.CNVS

$12.55M—

RFL

Rafael Holdings, Inc.RFL

$2K-97.4%

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleLongTermNotesPayable.

The official record: TuHURA Biosciences, Inc.’s 10-K, filed March 31, 2025, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s convertible debt (non-current)?: TuHURA Biosciences, Inc. (HURA) reported convertible debt (non-current) of $2.32M in Q4 2023.